https://www.selleckchem.com/pr....oducts/Gefitinib.htm
he treatment of male oligoasthenotspermia. Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval was not required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences.OSF Registration number DOI 10.17605/OSF.IO/2PM8T. Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval was not required. The re
Like
Comment
Share
